Catalyst Pharmaceuticals is a biopharmaceutical company based in Coral Gables, United States, dedicated to developing and commercializing therapies for people with debilitating and rare diseases. The company focuses on providing innovative treatments that address unmet medical needs, primarily serving customers within the United States.

Catalyst Pharmaceuticals has achieved significant milestones, including FDA approval for its therapies, which underscores its commitment to improving patient lives. The company's impact is evident through its contributions to the biopharmaceutical field, enhancing treatment options for rare disease patients.